We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · June 26, 2021

Safety and Efficacy of a Tubeless Automated Insulin Delivery System With Customizable Glucose Targets in an Outpatient Setting

Diabetes Technology & Therapeutics

 

Additional Info

Diabetes Technology & Therapeutics
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes
Diabetes Technol. Ther. 2021 Jun 01;23(6)410-424, GP Forlenza, BA Buckingham, SA Brown, BW Bode, CJ Levy, AB Criego, RP Wadwa, EC Cobry, RJ Slover, LH Messer, C Berget, S McCoy, L Ekhlaspour, RS Kingman, MK Voelmle, J Boyd, G O'Malley, A Grieme, K Kivilaid, K Kleve, B Dumais, T Vienneau, LM Huyett, JB Lee, J O'Connor, E Benjamin, TT Ly

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading